openPR Logo
Press release

VISTAAR added more AI capabilities to Clinical Insights

04-24-2020 03:54 PM CET | IT, New Media & Software

Press release from: VISTAAR

www.vistaar.ai

www.vistaar.ai

Clinical trial intelligence and insights from VISTAAR enables clinical teams to find deeper insights to design and plan clinical trials better

Continuing the legacy of bringing "context" based solutions to industry, VISTAAR add deeper AI capabilities to its "ClinIntel"module to support Pharmaceutical, Biotech, Medical Device companies as well CRO's. VISTAAR with it's ever growing clinical data sets, one of the key challenges had been on getting right answers quickly from it's internal diverse data.

When user knows what exactly they are looking for, ClinIntel provides straight search options. But if the answers need multi-data set analysis with multiple conditions, users leverage AI search.

Clinical Scientists or medical teams while planning a study or optimizing a design or protocol assessment, the search and screens are laid out from their perspective to help them get different scenarios data much faster for them to analyze and plan their next steps.

For Clinical operations teams, searches are positioned for them to search countries, investigators, sites details for them to pick right sets for better selection as this is key for study success.

In addition, users can leverage clinical insights that run across multiple country clinical studies.

About VISTAAR:

VISTAAR is most up-to-date compared to any other Tool or Data source because we use smart artificial intelligence methods all through out. With a unique combination of technology and smart people, you will get your strategy and trusted insights much faster. Over many years, VISTAAR has built deep and diverse data sets to help you or your Regulatory and Clinical projects. All this done at the best price point in the industry.

4 Independence way, Princeton, New Jersey, US - 08540

VISTAAR - Global Clinical and Regulatory Intelligence Software. For more information visit https://www.vistaar.ai/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release VISTAAR added more AI capabilities to Clinical Insights here

News-ID: 2023867 • Views:

More Releases from VISTAAR

Vistaar now with AI driven Regulatory Impact Assessment
Vistaar now with AI driven Regulatory Impact Assessment
June 19, 2025 - [Hammersmith Grove, London] - Vistaar, a leading innovator in regulatory technology solutions, today announced a major enhancement to its Regulatory Impact Assessment (RIA) offering through the integration of advanced Artificial Intelligence (AI) capabilities. This strategic upgrade represents a significant leap forward in how organizations navigate the dynamic and increasingly complex regulatory landscape. The enhanced RIA solution is now available on Vistaar's intelligent regulatory platform. By embedding AI-driven
11-12-2020 | Health & Medicine
VISTAAR
VISTAAR is empowering Biopharma & Device teams with Product & Label Intel module …
Vistaar’s enhanced Product Analytics & Label Intelligence modules to enable researchers find deep insights of approved/marketed products for development and commercial needs VISTAAR, a provider of Regulatory and Clinical Intelligence solutions with AI driven technology for the life sciences industry, brings enhanced Product Analytics & Label Intelligence modules for Drug & Devices. Product Analytics provides holistic insights to regulatory and product teams to research available products in market, current global clinical
VISTAAR Announces Addition of “ADVISORY Playbooks” to it’s Regulatory & Clinical Intelligence Platform
VISTAAR Announces Addition of “ADVISORY Playbooks” to it’s Regulatory & Cl …
VISTAAR released ADVISORY Playbooks to help small and mid-level companies who need advisory either as a primary strategy or as re-assurance / 2nd opinion to their internal strategies they formed for developing or launching new products or expanding to new countries. Lot of users when going into new markets, or planning to change their product elements and want to know the impact, introducing new product or to support their R&D teams,

All 4 Releases


More Releases for Clinical

Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions. Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes. Market Size and Growth The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical